PAGANELLI JOHN A 4

What Happened John A. Paganelli, a director of OPKO Health, was granted a 30,000-share award on June 18, 2026. The Form 4 lists this as a derivative acquisition (transaction code A) with an acquisition price of $0.00, so the reported transaction value is $0. This is a grant of equity (compensation/award), not an open-market purchase or sale.

Key Details

• Transaction date and price: 2026-06-18; 30,000 shares at $0.00 (derivative award, code A).
• Filing date: 2026-06-22 (appears timely — filing within two business days of the transaction).
• Shares owned after transaction: Not specified in the provided transaction excerpt; see the full Form 4 for post-transaction holdings.
• Notes: Classified as a derivative/award; no sale or cash paid listed. No 10b5-1, tax-withholding, or other footnotes provided in the summary supplied.

Context Grants like this are typically part of director compensation (e.g., restricted stock, RSUs, or performance awards) and don't necessarily signal the insider buying or selling stock in the market. Because the award was granted at $0, it represents compensation rather than a market transaction. For details on vesting, award type, or how this affects total holdings, review the full Form 4 filing.